6th Nov 2017 07:00
London, 6 November 2017
Georgia Healthcare Group PLC notice of 3Q and 9M 2017 Results
Georgia Healthcare Group PLC ("GHG") will publish its financial results for 3Q and 9M 2017 at 07:00 London time on Wednesday, 8 November 2017. The results announcement will be available on GHG's website at ghg.com.ge. The results discussion will take place on Friday, 10 November 2017, during the Investor Day held by GHG in Tbilisi at the following address: Biltmore Hotel Tbilisi (29 Shota Rustaveli Ave, 0108, Tbilisi, Georgia. Tel: +995 322 72 72 72).
Name of authorised official of issuer responsible for making notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 35 hospitals and ten Polyclinic clusters (consisting of 13 district Polyclinics and 24 express outpatient clinics), as at 30 June 2017. GHG is the single largest market participant, accounting for 24.6% of total hospital bed capacity in the country, as of 30 June 2017. From January 2017, GHG become the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 29% market share based on 31 December 2015 revenue figures. GHG is the second largest provider of medical insurance in Georgia with a 30.9% market share based on net insurance premiums earned and approximately 135,000 insurance customers as at 30 June 2017. GHG employed a total of c.14,800 people as at 30 June 2017, including c.3,400 physicians.
For further information, please visit www.ghg.com.ge or contact:
Nikoloz Gamkrelidze | Irakli Gogia | Ketevan Kalandarishvili |
CEO | CFO | Head of Investor Relations |
+995 322 550505 (5077) | +995 322 550505 (5088) | +995 322 550505 (5079) |
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities
Related Shares:
GHG.L